Kaskela Law LLC Investigates Blue Ridge Bankshares Shareholders
Kaskela Law LLC is making headlines as it launches an investigation into Blue Ridge Bankshares, Inc. (NYSE: BRBS). This investigation is particularly focused on long-term shareholders of Blue Ridge, who may have suffered due to recent issues related to the company's financial reporting and practices.
Background of the Investigation
A securities fraud complaint has recently come to light regarding Blue Ridge Bankshares, detailing events that occurred from mid-February to the end of October. The complaint alleges that during this period, both the company and some of its top executives made a series of misleading statements about the company's performance and future prospects, which has caught the interest of law firms that specialize in protecting investor rights.
Details of the Allegations
The allegations in the complaint assert that Blue Ridge Bankshares participated in deceptive practices, particularly concerning its reported financial condition. Notably, a press release on April 27 reported that nonperforming loans surged dramatically from $18.6 million at the end of 2022 to a concerning $30.7 million in the First Quarter of 2023. This alarming news resulted in a significant drop in the company’s stock price, which fell over 28% within a week.
Subsequent Financial Reports
The company's troubles continued with further unsettling news. A second report, released on July 31, revealed even more deterioration. By June 30, 2023, Blue Ridge Bankshares had classified loans totaling $86.1 million as non-performing. This revelation caused the stock to decline again, with a drop of around 8.5% following the announcement.
Critical SEC Filing Implications
To make matters worse, Blue Ridge's Form 8-K filing on October 31 indicated that the company instructed investors to disregard its previous financial reports for fiscal year 2022 as well as for the First and Second quarters of 2023. This drastic action led to yet another significant decrease in stock value, causing it to drop nearly 33% to close at $2.09.
Reasons for Shareholders to Act
The ongoing investigation by Kaskela Law LLC is critical for shareholders who purchased their shares in Blue Ridge before February 3, 2023. The firm's mission is to determine if the company's board may have failed in its fiduciary duties and complied with securities laws amid these troubling developments.
Contacting Kaskela Law LLC
Shareholders who believe they might have been wronged are encouraged to reach out to Kaskela Law LLC for more information about their rights and possible legal options. D. Seamus Kaskela, Esq. and Adrienne Bell, Esq. are available to address inquiries directly at (484) 229 – 0750.
About Kaskela Law LLC
Kaskela Law LLC is dedicated to representing investors in matters related to securities fraud and corporate governance. The firm is committed to supporting its clients, working on a contingent basis to ensure their rights are protected and their voices are heard.
Frequently Asked Questions
What prompted Kaskela Law LLC to investigate Blue Ridge Bankshares?
The investigation was prompted by allegations of securities fraud and misleading financial disclosures that adversely affected shareholders.
How did the stock of Blue Ridge Bankshares respond to the recent financial news?
In light of the troubling announcements, the stock saw a significant drop, including a decline of more than 28% following the First Quarter 2023 financial report.
What timeline does the investigation cover?
The investigation looks at events from February 3 to October 31, 2023, with significant findings occurring in various press releases and SEC filings during this timeline.
What steps should BRBS shareholders take if they're impacted?
Affected shareholders should reach out to Kaskela Law LLC to learn about their legal rights and potential actions in light of the investigation.
What areas does Kaskela Law LLC focus on?
Kaskela Law LLC specializes in securities fraud, corporate governance issues, and merger & acquisition litigation, providing essential support for investors.
